{
  "docId": "019de071-35ef-72cc-b3e0-43bd893f2974",
  "docSlug": "02aecfc3c422ab6542121e72cecdcca1",
  "documentTitle": "Absci | IPO Presentation Deck | 65 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 65,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_disclosure",
  "function": "other",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "This is a standard IPO offering summary slide.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-35ef-72cc-b3e0-43bd893f2974/3",
  "deckHref": "/decks/019de071-35ef-72cc-b3e0-43bd893f2974",
  "deckJsonHref": "/decks/019de071-35ef-72cc-b3e0-43bd893f2974.json",
  "deckAnchorHref": "/decks/019de071-35ef-72cc-b3e0-43bd893f2974#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "table",
      "text": "Issuer (Exchange / Ticker): Absci Corp. (Nasdaq / ABSI)\nBase Offering Size: $200 million (100% primary, at the midpoint of the range)\nShares Offered: 12,500,000 shares (100% primary)\nOverallotment Option: 1,875,000 shares (100% primary, 15% of base deal)\nFiling Range: $15.00 – $17.00 per share\nLock-up Period: 180 days for the Company, directors, officers and substantially all security holders\nUse of Proceeds: The Company intends to use the net proceeds from this offering: To further invest in expanding the Integrated Drug Creation Platform’s capabilities; For continued growth of business development organization and activities; For general corporate purposes, including working capital, capital expenditures, and operating expenses. The Company may also use a portion of the remaining net proceeds, if any, to acquire complementary businesses, products, services or technologies, including scientific expertise, although has no binding agreements or commitments to do so at this time\nJoint Bookrunners: J.P. Morgan, Credit Suisse, BofA Securities, Cowen, Stifel\nStabilization Agent: J.P. Morgan\nExpected Pricing: Wednesday, July 21st, 2021",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b46e83c-321e-4036-aca0-28a011ff643e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Offering summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e2faca0-a3ea-45d7-b83e-64dc8aff511c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}